What Is End-of-Life Care for Neuroendocrine Tumors With Liver Metastases?
By CRYSTAL BAI •
The short answer: NETs with liver metastases cause carcinoid syndrome (flushing, diarrhea, carcinoid heart disease) alongside liver failure. End-of-life care manages these specific hormonal syndromes, liver-related symptoms, and pain through specialized palliative care and somatostatin analog management.
Understanding NET Liver Metastases at End of Life
Well-differentiated neuroendocrine tumors (NETs) with liver metastases can be managed for years with somatostatin analogs (octreotide, lanreotide), PRRT, liver-directed therapies, and systemic agents. When these approaches are exhausted and the liver is extensively involved, end-of-life care requires managing the unique symptom burden of NET-related hormonal excess alongside progressive liver disease.
Carcinoid Syndrome Management at End of Life
Carcinoid syndrome — flushing, diarrhea, bronchospasm — can become severe as liver disease progresses and functional hepatic clearance declines. Continued or escalating doses of long-acting somatostatin analogs help. Carcinoid crisis (severe acute syndrome, often triggered by procedures) requires IV octreotide management. Hospice teams must be familiar with these NET-specific complications.
Carcinoid Heart Disease
Carcinoid heart disease (tricuspid and pulmonary valve fibrosis) from serotonin exposure affects up to 50% of patients with carcinoid syndrome and can cause right heart failure. Managing carcinoid heart disease at end of life includes diuretics for fluid retention, symptom management for dyspnea, and careful positioning and activity guidance.
Liver Disease Symptom Management
Extensive liver metastases cause hepatic dysfunction — jaundice, encephalopathy, ascites, and coagulopathy — requiring standard hepatic palliative management alongside NET-specific care. Early hospice enrollment ensures comprehensive symptom management.
Frequently Asked Questions
What is carcinoid syndrome at end of life?
Carcinoid syndrome — flushing, diarrhea, bronchospasm — can worsen as liver disease progresses in NET patients. Somatostatin analogs and careful symptom management remain central at end of life.
When should a NET patient with liver metastases consider hospice?
Hospice is appropriate when liver-directed therapies and systemic treatment are exhausted, liver function is significantly impaired, and prognosis is six months or less.
What symptoms are managed at end of life with NET liver metastases?
Key symptoms include carcinoid syndrome, carcinoid heart disease, liver failure (ascites, encephalopathy, jaundice), and pain from liver distension.
Can a death doula help a family facing NET end of life?
Yes. A death doula provides companionship, family support, and can help ensure hospice teams have adequate information about NET-specific symptom management needs.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.